Literature DB >> 17390062

Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry.

Yuichi Sanada1, Kazuhiro Yoshida, Hiroyuki Itoh.   

Abstract

The purpose of this study was to compare features of computed tomography (CT) and histologic features of hepatocellular carcinoma (HCC) of up to 2 cm in diameter with the immunohistochemical staining pattern of claudin-10, a recently identified prognostic factor for resected HCC. Twelve cases of resected HCC of up to 2 cm in diameter were assessed retrospectively. Preoperative dynamic CT was reviewed, and three enhancement patterns were identified. Type I (n=6) was defined as a pattern of hyperenhancement throughout the tumor in early-phase CT, decreasing to hypoenhancement in late-phase CT (high-low), a finding characteristic of HCC. Type II tumors (n=2) appeared as an area of hyperenhancement in early-phase CT, and an area of hyperenhancement in late-phase CT (low-high). Histologically, type II tumors were considered unusual types, and included combined hepatocellular-cholangiocarcinoma and scirrhous HCC. In type III tumors (n=4), high-low, low-high and low-low components were observed. Type III tumors showed multinodular-type morphology and comprised both moderately and poorly differentiated HCC with marked necrosis and fibrosis. Each nodule was divided by fibrous septa. In three of the four type III cases, recurrence occurred within 6 months after resection. Immunohistochemistry of claudin-10 showed positivity in five of the 12 cases, including four type III cases. Results of this study suggest that type III tumors have greater malignant potential than the other tumor types.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390062

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.

Authors:  G W Huang; X Ding; S L Chen; L Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2011-06-07       Impact factor: 4.553

2.  Research on focal nodular hyperplasia with MSCT and postprocessing.

Authors:  Yuan-Jian Liu; Wei-Jun Fan; Zhi-Dong Yuan; Peng-Cheng Liu; Chun-Rong Wang; Wei-Qiang Yan; Su-Mei Wang; Jun-Hui Chen; Zheng Liu
Journal:  World J Gastroenterol       Date:  2009-10-14       Impact factor: 5.742

3.  The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.

Authors:  Ryo Shimizu; Hideyuki Tamai; Yoshiyuki Mori; Naoki Shingaki; Shuya Maeshima; Junya Nuta; Yoshimasa Maeda; Kosaku Moribata; Yosuke Muraki; Hisanobu Deguchi; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Hepatol Int       Date:  2015-11-03       Impact factor: 6.047

4.  Predicting peritumoral Glisson's sheath invasion of intrahepatic cholangiocarcinoma with preoperative CT imaging.

Authors:  Yingfan Mao; Yong Zhu; Yudong Qiu; Weiwei Kong; Liang Mao; Qun Zhou; Jun Chen; Jian He
Journal:  Quant Imaging Med Surg       Date:  2019-02

5.  Rapid progression of combined hepatocellular carcinoma and cholangiocarcinoma.

Authors:  Sachin S Saboo; Katherine M Krajewski; Jyothi P Jagannathan; Kevin N O'Regan; Robert Odze; Nikhil Ramaiya; Brian M Wolpin
Journal:  Cancer Imaging       Date:  2011-03-31       Impact factor: 3.909

6.  Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.

Authors:  Kenichiro Nakachi; Hideyuki Tamai; Yoshiyuki Mori; Naoki Shingaki; Kosaku Moribata; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Jun Kato; Masao Ichinose
Journal:  Cancer Imaging       Date:  2014-04-22       Impact factor: 3.909

7.  E7 oncoprotein from human papillomavirus 16 alters claudins expression and the sealing of epithelial tight junctions.

Authors:  Perla Yaceli Uc; Jael Miranda; Arturo Raya-Sandino; Lourdes Alarcón; María Luisa Roldán; Rodolfo Ocadiz-Delgado; Enoc Mariano Cortés-Malagón; Bibiana Chávez-Munguía; Georgina Ramírez; René Asomoza; Liora Shoshani; Patricio Gariglio; Lorenza González-Mariscal
Journal:  Int J Oncol       Date:  2020-07-29       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.